RESUMEN
The aim of this study is to elucidate the structure and investigate the antimicrobial activity of an ulvan obtained by water extraction from green seaweed Ulva reticulata collected at Nha Trang sea of Vietnam by using IR, NMR, SEC-MALLS and SAXS methods. The ulvan is composed of rhamnose, galactose, xylose, manose and glucose (mole ratio Rha: Gal: Xyl: Man: Glu = 1:0.12:0.1:0.06:0.03), uronic acid (22.5%) and sulphate groups (17.6%). Chemically structural determination showed that the ulvan mainly composed of disaccharide [â4)ß-D-GlcA(1â4)α-L-Rha3S-(1â]. The results from SAXS indicated that ulvan under study has a rod-like bulky chain conformation. Ulvan from U. reticulata showed high antimicrobial activity, with inhibition zone diameter of 20 mm against Enterobacter cloace and 18 mm against Escherichia coli.
Asunto(s)
Antibacterianos/aislamiento & purificación , Polisacáridos/química , Polisacáridos/aislamiento & purificación , Ulva/química , Antibacterianos/química , Antibacterianos/farmacología , Antiinfecciosos/química , Antiinfecciosos/aislamiento & purificación , Antiinfecciosos/farmacología , Conformación Molecular , Polisacáridos/farmacología , Algas Marinas/química , Análisis Espectral , VietnamRESUMEN
The structure of an ulvan obtained by water extraction from green seaweed Ulva lactuca was elucidated by using IR, NMR, SEC-MALL and ESIMS methods. The ulvan was also evaluated for its cytotoxic effects on three human cancer cell lines. The results showed that the ulvan was composed of rhamnose, galactose, xylose, manose, glucose (with a mole ratio of Rha: Gal: Xyl: Man: Glu equal to 1: 0.03: 0.07: 0.01: 0.06), uronic acid (21.5%) and sulfate content (18.9%) with a molecular weight of 347000. This ulvan mainly consists of disaccharide [â4)-ß-d-GlcA-(1â4)-α-l-Rha3S-(1â] and other minor disaccharide ß-GlcA-(1â2)-α-Xyl and ß-GlcA-(â2)-α-Rha. The ulvan showed a significant cytotoxic activity against hepatocellular carcinoma (IC50 29.67±2.87µg/ml), human breast cancer (IC50 25.09±1.36µg/ml), and cervical cancer (IC50 36.33±3.84µg/ml).